The meeting has the category of a classic educational activity where many people come to teach, to learn, and also to discuss the value of how standard as well as new approaches are being incorporated into the management of ovarian cancer. In this symposium, held in one day, we cover all hot topics concerning diagnosis, biology and therapy of ovarian cancer.
Cancer rates across the Middle East are expected to double between 2012 and 2030, according to World Health Organisation (WHO) estimates—the highest relative increase of any region globally. This rise is caused by a combination of environmental factors, lifestyle choices and increasing detection rates, but it is further driven by limited access to high-quality treatment and care. How can a holistic, affordable and sustainable system provide care for all?
Building on global dialogues at War on Cancer events in Europe, Latin America and Asia, War on Cancer: Middle East 2019 will advance the conversation by bringing together policymakers, industry leaders, health-care providers, insurers, investors, scientists, technologists and prominent thinkers to explore how a cancer-care pathway should be designed, funded and implemented across the Middle East. What needs to be done to improve prevention, screening, early detection and treatment, and how can policymakers and regulators educate the region’s population about healthy lifestyle choices? How can stakeholders ensure that care is not just for the wealthy, but accessible to all members of society?
The biennial congress "Quality of Cancer Care" (QoCC) will be held in 2019 under the motto "Quality means learning from care". The organizers are the German Cancer Society (DKG) and the Association of German Tumor Centers (ADT).
The War on Cancer Asia Summit is part of our global initiative to catalyse fresh debate and drive progress in cancer control. The event will gather a diverse audience from the medical, practitioner, and provider communities, together with policymakers, patients, advocates, NGOs and civil society. We will examine the state of play of National Cancer Control Plans across Asia, explore best practices and areas for improvement, and create a manifesto for accelerated action and change.
Patient groups are beginning to emerge across Asia, and patient advocacy is starting to find its voice. Against the backdrop of a rising cancer burden and increasing demand for quality care, the summit will aim to accelerate the pace of patient advocacy across the region to drive better care and policy. We will draw on case studies showing effective collaboration among patient groups, and between these groups and policymakers. The summit will explore where working together has transformed policies and practices in prevention, early detection, treatment and care. We will also examine the potential pitfalls as we place these examples in the regional context.
A mantra on the role of advocacy in modern health care systems asserts: “No decision about me, without me.” Our mission is to create a workable vision that points the way towards making this mantra a reality for cancer care in Asia. Join us and add your support.
The Theme of the Radiology and Oncology -2019 is “Practice, Research & Leadership: Weaving it all together "which covers the wide range of critically important sessions in the field of Oncology, Radiology, Cancer, and Imaging. This multidisciplinary multi-specialty oncology course will cover all aspects of cancer imaging and intervention. The objective of this meeting is to share the foremost updated knowledge on the radiology and the novel therapeutic options in Cancer treatment. We will gather academicians and young inspired scientists from all around the world involved in researchers at the cutting edge in the study of the radiology and oncology.
ESTRO 38 will offer to us all, as professionals of oncology, the chance to share knowledge, practice and advances in the field, within the ever warm and dynamic environment of the ESTRO meetings.
‘Targeting optimal care, together’ will be the theme of ESTRO 38 and through these few, however impactful words, the Scientific and organising committees would like to put a spotlight on the multiprofessional and multidisciplinary aspect of our specialty. The theme also represents our strength: we are all working towards a common goal for improved patient outcomes, and this will be expressed throughout the scientific programme...
2019 ASCO Annual Meeting
Caring for Every Patient, Learning from Every Patient | #ASCO19
The 2019 International Cancer Screening Network (ICSN) Conference will take place in Rotterdam, the Netherlands. The meeting is jointly organized by the department of Public Health at the Erasmus MC University Medical Center Rotterdam in the Netherlands and the Center for Global Health at the U.S. National Cancer Institute (NCI).
The theme of this year’s conference will be “Screening in Balance”, emphasizing the importance of continuously weighing the benefits and harms of cancer screening programs. The focus of the conference will be on collaborative research that fosters efficient and effective approaches to cancer control worldwide through organized approaches to population-based cancer screening.
Meeting topics will include, but are not limited to:
Novel strategies in Screening & BIG DATA
Cancer screening in low and middle income countries
Lung cancer screening
Controversial issues in screening (e.g. treatment effects, false positives, and overtreatment)
Impact of screening policies and strategies
Communicating screening in balance (engaging patients and professionals)
Reaching the hard-to-reach populations
The meeting will be open to cancer screening research across all cancer sites, for which population-based screening is being delivered, piloted or seriously considered.
The Cancer Meeting going to take place during June 2019 at Marriott Hotel Al Jaddaf, Oud Metha Road, Al Jaddaf Area, Dubai, United Arab Emirates is the premier platform not only for the presentation of new science, but also for unique networking opportunities. This Meeting will be the largest international gathering of clinicians, researchers and scientists in the field of cancer and oncology. With delegates from more than 100 countries attending will provide the ideal forum to discuss the latest findings, put them into context and really understand how they affect your practice day to day. We encourage physicians, nurses, other clinicians, researchers and scientists as well as patients and advocates in the cancer field and those interested in any aspect of oncology to attend this Meeting. It is only through an exchange of the widest variety of research that we can offer the best program and benefits to members and patients.
European Cancer Care: across boarders.